ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

MRNA-1469

A development code. Also written as “mRNA-1469”.

Its studies are led by Moderna.

Furthest: phase 1, since Jul 27, 20262 company-led studies, 2 open or runningNext primary completion: Sep 30, 2027 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Moderna22 open or runningphase 1since Jul 27, 2026Jul 27, 2026Sep 30, 2027phase 1 · NCT07737717

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 27, 2026First study: phase 1 study in Ebola-Bundibugyo Virus Disease (Ebola-BDBV)First studyNCT07737717 · 84 enrolled · Canada
  2. Oct 30, 2026Phase 1 study in Ebola-Bundibugyo Virus Disease (Ebola-BDBV)NCT07919197 · 224 planned · Uganda

Ahead

  1. Sep 30, 2027Primary completion: phase 1 study in Ebola-Bundibugyo Virus Disease (Ebola-BDBV)NCT07737717
  2. Feb 1, 2028Primary completion: phase 1 study in Ebola-Bundibugyo Virus Disease (Ebola-BDBV)NCT07919197

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07919197Ebola-Bundibugyo Virus Disease (Ebola-BDBV) · Uganda1Not yet recruitingFeb 1, 2028224
NCT07737717Ebola-Bundibugyo Virus Disease (Ebola-BDBV) · Canada1Active, not recruitingSep 30, 202784

How it is read

Names in the registry

  • “mRNA-1469”, 2 entries

Codes read as this program: MRNA1469.

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.